Repurposed drugs - Access to the European Market

- AI and data-driven approaches to drug repurposing - IP considerations and opportunities - Regulatory considerations: Data exclusivity, regulatory pathways - Market Access strategies - Strategic decisions at the edge of IP - Regulatory Affairs - HTAThis online seminar equips regulatory affairs, IP, legal and market access professionals with practical strategies to navigate the complex journey from drug repurposing to European market authorisation and market access.LernzieleThis seminar provides comprehensive insights into the regulatory, IP and market access challenges of bringing repurposed drugs to the European market.- Participants will gain practical insights into: - Data-driven approaches to drug repurposing using AI technologies - IP strategies for protecting repurposed drugs - Regulatory pathways for repurposed drugs - Market access considerations, particularly EU HTA, German AMNOG procedures and recent legal novelties- After having attended the seminar you will be able to align IP protection, regulatory pathways and HTA requirements into cohesive strategic decisions.ZielgruppenThis online seminar is designed for regulatory affairs, IP, legal and market access professionals seeking to bring repurposed drugs to market. A basic understanding of regulatory and IP requirements as well as general market access principles is recommended.